Xia Y - Search Results

1

Wu Y, Xie Z, Deng S, Xia Y, Lei X, Yang X. Wu Y, et al. Among authors: xia y. Comb Chem High Throughput Screen. 2023;26(7):1285-1297. doi: 10.2174/1386207325666220909104803. Comb Chem High Throughput Screen. 2023. PMID: 36093821 Review.

2

Lactic acid in tumor invasion.

Niu D, Luo T, Wang H, Xia Y, Xie Z. Niu D, et al. Among authors: xia y. Clin Chim Acta. 2021 Nov;522:61-69. doi: 10.1016/j.cca.2021.08.011. Epub 2021 Aug 13. Clin Chim Acta. 2021. PMID: 34400170 Review.

3

Efficient biodegradation of straw and persistent organic pollutants by a novel strategy using recombinant Trichoderma reesei.

Xia Y, Lin X. Xia Y, et al. Bioresour Bioprocess. 2022 Aug 29;9(1):91. doi: 10.1186/s40643-022-00581-9. Bioresour Bioprocess. 2022. PMID: 38647641

4

Effects of soil pH on the growth, soil nutrient composition, and rhizosphere microbiome of Ageratina adenophora.

Xia Y, Feng J, Zhang H, Xiong D, Kong L, Seviour R, Kong Y. Xia Y, et al. PeerJ. 2024 Apr 16;12:e17231. doi: 10.7717/peerj.17231. eCollection 2024. PeerJ. 2024. PMID: 38646477 Free PMC article.

5

Erratum to "PGAM5-Mediated PHB2 Dephosphorylation Contributes to Diabetic Cardiomyopathy by Disrupting Mitochondrial Quality Surveillance".

Zou R, Tao J, He J, Wang C, Tan S, Xia Y, Chang X, Li R, Wang G, Zhou H, Fan X. Zou R, et al. Among authors: xia y. Research (Wash D C). 2024 Feb 29;7:0325. doi: 10.34133/research.0325. eCollection 2024. Research (Wash D C). 2024. PMID: 38646464 Free PMC article.

6

Do Age and Timing Influence the Outcomes of Single-stage Reconstruction of Multiple Ligament Knee Injuries? 5-10 Years Follow Up.

He J, Geng B, Xu P, Xia Y. He J, et al. Among authors: xia y. Orthop Surg. 2024 Apr 21. doi: 10.1111/os.14067. Online ahead of print. Orthop Surg. 2024. PMID: 38644618

7

[Exploration and practice of cardio-oncology].

Liu Y, Zhang XX, Fang FQ, Xia YL. Liu Y, et al. Among authors: xia yl. Zhonghua Yi Xue Za Zhi. 2024 Apr 23;104(16):1341-1346. doi: 10.3760/cma.j.cn112137-20230925-00547. Zhonghua Yi Xue Za Zhi. 2024. PMID: 38644280 Chinese.

8

Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.

Frentzas S, Austria Mislang AR, Lemech C, Nagrial A, Underhill C, Wang W, Wang ZM, Li B, Xia Y, Coward JIG. Frentzas S, et al. Among authors: xia y. J Immunother Cancer. 2024 Apr 19;12(4):e008037. doi: 10.1136/jitc-2023-008037. J Immunother Cancer. 2024. PMID: 38642937 Clinical Trial.

9

Longitudinal pulse-synchronous bouncing during catheter angiography-A phenomenon specific to spinal hemangioblastomas.

Xia Y, Pennington Z, Ahmed AK, Sciubba D, Gailloud P. Xia Y, et al. World Neurosurg. 2024 Apr 18:S1878-8750(24)00637-5. doi: 10.1016/j.wneu.2024.04.074. Online ahead of print. World Neurosurg. 2024. PMID: 38642834

10

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Diseases and Injuries Collaborators. GBD 2021 Diseases and Injuries Collaborators. Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757-8. Online ahead of print. Lancet. 2024. PMID: 38642570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,943 results

Search Page